SCHEMBL9058299

SCHEMBL9058299

CNC1=NCCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9054406 0.76
SCHEMBL9056987 0.71 ALDH1A1 (0.47)
SCHEMBL9054600 0.69 ALDH1A1 (0.60)
Xylazine SCHEMBL15487 0.68 LMNA (1.00)
SCHEMBL762220 0.67
SCHEMBL12890659 0.65
SCHEMBL5991335 0.63
SCHEMBL8142930 0.63
SCHEMBL12217234 0.62
SCHEMBL13492911 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021102330-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN SYNVENTA LLC (US) 2021-05-27 WO disclosed
WO-1996014842-A1 SUBSTITUTED HETEROCYCLES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-05-23 WO disclosed